[Federal Register: September 21, 2000 (Volume 65, Number 184)]
[Notices]               
[Page 57196]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr21se00-80]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institute of Health

 
Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Office of AIDS Research Advisory Council.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Office of AIDS Research Advisory Council.
    Date: October 5-6, 2000.
    Time: October 5, 2000, 9 a.m. to 5 p.m.
    Agenda: International research priorities to address the global 
AIDS pandemic and the role of the National Institutes of Health 
(NIH) in this critical research area.
    Place: 9000 Rockville Pike, Building 31, Conference Room 10, 
Bethesda, MD 20892.
    Time: October 6, 2000 a.m. to 12 p.m.
    Agenda: Vaccine Clinical Trials.
    Place: 9000 Rockville Pike, Building 31, Conference Room 10, 
Bethesda, MD 20892.
    Contact Person: Linda Reck, Head, Program, Planning and 
Evaluation, Office of AIDS Research, NIH, Bethesda, MD 20892, (301) 
402-8655.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.187, Undergraduate 
Scholarship Program for Individuals from Disadvantaged Backgrounds; 
93.22, Clinical Research Loan Repayment Program for Individuals from 
Disadvantaged Backgrounds; 93.232, Loan Repayment Program for 
Research Generally; 93.39, Academic Research Enhancement Award; 
93.936, NIH Acquired Immunodeficiency Syndrome Research Loan 
Repayment Program, National Institutes of Health, HHS)


    Dated: September 12, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-24240 Filed 9-20-00; 8:45 am]
BILLING CODE 4140-01-M